The crystal structure of multidrug-resistance regulator RamR with multiple drugs

被引:79
|
作者
Yamasaki, Suguru [1 ,2 ]
Nikaido, Eiji [1 ,2 ]
Nakashima, Ryosuke [3 ]
Sakurai, Keisuke [3 ]
Fujiwara, Daisuke [4 ]
Fujii, Ikuo [4 ]
Nishino, Kunihiko [1 ]
机构
[1] Osaka Univ, Inst Sci & Ind Res, Div Special Projects, Lab Microbiol & Infect Dis, Ibaraki, Osaka 5670047, Japan
[2] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Inst Sci & Ind Res, Div Special Projects, Lab Cell Membrane Struct Biol, Ibaraki, Osaka 5670047, Japan
[4] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Naka Ku, Sakai, Osaka 5998531, Japan
来源
NATURE COMMUNICATIONS | 2013年 / 4卷
关键词
ENTERICA SEROVAR TYPHIMURIUM; EFFLUX PUMPS; SALMONELLA-TYPHIMURIUM; KLEBSIELLA-PNEUMONIAE; TETR FAMILY; EXPRESSION; BACTERIA; MUTATIONS; ACRAB; SUSCEPTIBILITY;
D O I
10.1038/ncomms3078
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
RamR is a transcriptional repressor of the gene-encoding RamA protein, which controls the expression of the multidrug efflux system genes acrAB-tolC. RamR is an important multidrug-resistance factor, however, its structure and the identity of the molecules to which it responds have been unknown. Here we report the crystal structure of RamR in complex with multiple drugs, including berberine, crystal violet, dequalinium, ethidium bromide and rhodamine 6G. All compounds are found to interact with Phe155 of RamR, and each compound is surrounded by different amino acid residues. Binding of these compounds to RamR reduces its DNA-binding affinity, which results in the increased expression of ramA. Our results reveal significant flexibility in the substrate-recognition region of RamR, which regulates the bacterial efflux participating in multidrug resistance.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Mammalian multidrug-resistance proteins (MRPs)
    Slot, Andrew J.
    Molinski, Steven V.
    Cole, Susan P. C.
    ESSAYS IN BIOCHEMISTRY: ABC TRANSPORTERS, 2011, 50 : 179 - 207
  • [43] MULTIDRUG-RESISTANCE IN CANCER-CHEMOTHERAPY
    PATEL, NH
    ROTHENBERG, ML
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) : 1 - 13
  • [44] GENETICS AND BIOCHEMISTRY OF YEAST MULTIDRUG-RESISTANCE
    BALZI, E
    GOFFEAU, A
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1994, 1187 (02): : 152 - 162
  • [45] STRUCTURE-ACTIVITY RELATIONSHIP OF VERAPAMIL ANALOGS AND REVERSAL OF MULTIDRUG-RESISTANCE
    TOFFOLI, G
    SIMONE, F
    CORONA, G
    RASCHACK, M
    CAPPELLETTO, B
    GIGANTE, M
    BOIOCCHI, M
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (08) : 1245 - 1255
  • [46] EXPLOITING MULTIDRUG-RESISTANCE TO TREAT CANCER
    GOTTESMAN, MM
    AMBUDKAR, SV
    NI, B
    ARAN, JM
    SUGIMOTO, Y
    CARDARELLI, CO
    PASTAN, I
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 : 677 - 683
  • [47] PROTEIN-KINASES AND MULTIDRUG-RESISTANCE
    EPAND, RM
    STAFFORD, AR
    CANCER JOURNAL - FRANCE, 1993, 6 (03): : 154 - 158
  • [48] CHEMOSENSITIZERS TO OVERCOME AND PREVENT MULTIDRUG-RESISTANCE
    GERMANN, UA
    HARDING, MW
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (21) : 1573 - 1575
  • [49] REVERSAL OF MULTIDRUG-RESISTANCE BY VERAPAMIL ANALOGS
    PEREIRA, E
    TEODORI, E
    DEI, S
    GUALTIERI, F
    GARNIERSUILLEROT, A
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) : 451 - 457
  • [50] INTRACELLULAR PH AND THE CONTROL OF MULTIDRUG-RESISTANCE
    SIMON, S
    ROY, D
    SCHINDLER, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (03) : 1128 - 1132